SCHEMBL12373611

SCHEMBL12373611

CCn1c(C(C)NS(=O)(=O)c2cc(F)ccc2F)cnc1Oc1ccc(C)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 2/20 0.40
S1PR1 P21453 5/20 0.39
S1PR3 Q99500 1/20 0.39
MAPT P10636 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TP53 P04637 2/20 0.36
AXL P30530 1/20 0.35
NR3C2 P08235 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
HTR1A P08908 1/20 0.35
DRD2 P14416 1/20 0.35
HTR7 P34969 1/20 0.35
HTR6 P50406 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HTT P42858 2/20 0.35
P2RX3 P56373 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12373692 0.94 S1PR1 (0.40) KAT6AS1PR1S1PR3P2RX3
SCHEMBL12373565 0.93 TRIM24 (0.40) S1PR1S1PR3MAPTTP53MEN1
SCHEMBL12373584 0.93 KAT6A (0.40) KAT6AS1PR1S1PR3MAPTTP53
SCHEMBL12373679 0.92 S1PR1 (0.42) KAT6AS1PR1S1PR3KMT2A
SCHEMBL12373677 0.91 NR3C1 (0.36) S1PR1S1PR3MAPTTP53MEN1
SCHEMBL12373639 0.91 S1PR1 (0.38) KAT6AS1PR1S1PR3NPSR1MEN1
SCHEMBL12373589 0.89 S1PR1 (0.40) S1PR1S1PR3MAPTTP53P2RX3
SCHEMBL12373668 0.89 KMT2A (0.36) S1PR1S1PR3MAPTTP53MEN1
SCHEMBL12373591 0.89 ALDH1A1 (0.38) KAT6AS1PR1S1PR3NPSR1TP53
SCHEMBL12373609 0.88 S1PR1 (0.38) S1PR1S1PR3NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994204-B2 Binding inhibitor of sphingosine-1-phosphate TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-08-09 US disclosed
US-7994204-B2 Binding inhibitor of sphingosine-1-phosphate TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-08-09 US disclosed
US-20090182144-A1 BINDING INHIBITOR OF SPHINGOSINE-1-PHOSPHATE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-07-16 US disclosed
US-20090182144-A1 BINDING INHIBITOR OF SPHINGOSINE-1-PHOSPHATE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090182144-A1 BINDING INHIBITOR OF SPHINGOSINE-1-PHOSPHATE S1PR1, S1PR3, S1PR2 KAT6A 4593/4885S1PR1 1/4885S1PR3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.